J. Hendrikx

发表

A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute

J. Beijnen, K. Heinhuis, Hannerieke J. Barkman, 2020, International Journal of Clinical Pharmacy.

Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.

J. Schellens, H. Rosing, J. Beijnen, 2014, Bioanalysis.

Improving Appropriate Prescribing For Geriatric Patients Using a Clinical Decision Support System

J. V. van Campen, M. V. van Agtmael, J. Tichelaar, 2022, Innovations in pharmacy.

Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours

J. Beijnen, A. Bergman, B. van Triest, 2021, Cancer Chemotherapy and Pharmacology.

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

J. Schellens, H. Rosing, J. Beijnen, 2013, International journal of cancer.

Genetically modified mouse models for oral drug absorption and disposition.

J. Beijnen, A. Schinkel, Seng Chuan Tang, 2013, Current opinion in pharmacology.

Severe Lactic Acidosis in a Diabetic Patient after Ethanol Abuse and Floor Cleaner Intake

J. Schellens, J. Beijnen, A. Huitema, 2014, Basic & clinical pharmacology & toxicology.

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient’s therapy course

I. Walraven, M. Tesselaar, M. Sinaasappel, 2021, PloS one.

A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir

J. Schellens, H. Rosing, J. Beijnen, 2019, Clinical Cancer Research.

A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.

J. Schellens, H. Rosing, J. Beijnen, 2017, European journal of cancer.

P-gp and taxanes

J. Beijnen, A. Schinkel, J. Hendrikx, 2014, Oncoscience.

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel

H. Rosing, J. Beijnen, E. van de Steeg, 2015, International journal of cancer.

Translational pharmacology and bioanalysis of oral taxanes

J. Hendrikx, 2014 .

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Y. Seimbille, B. Cornelissen, W. Szymański, 2021, EJNMMI Radiopharmacy and Chemistry.

P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice.

H. Rosing, J. Beijnen, A. Schinkel, 2015, Molecular pharmaceutics.

No relation between docetaxel administration route and high‐grade diarrhea incidence

J. Schellens, H. Rosing, J. Beijnen, 2020, Pharmacology research & perspectives.

Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

J. Schellens, H. Rosing, J. Beijnen, 2016, International journal of cancer.

Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer

J. Schellens, J. Beijnen, S. Rottenberg, 2015, The AAPS Journal.

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation

J. Schellens, H. Rosing, J. Beijnen, 2014, British Journal of Cancer.

Robot-assisted Prostate-specific Membrane Antigen-radioguided Salvage Surgery in Recurrent Prostate Cancer Using a DROP-IN Gamma Probe: The First Prospective Feasibility Study.

H. G. van der Poel, T. Maurer, M. Donswijk, 2022, European Urology.

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology

Jennifer H. Martin, J. Ciccolini, E. Chatelut, 2021, Pharmacology research & perspectives.

The development and validation of a high performance liquid chromatography method to determine the radiochemical purity of [177Lu]Lu-HA-DOTA-TATE in pharmaceutical preparations.

J. Beijnen, L. van Andel, E. Aalbersberg, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA

J. Nonnekens, E. de Blois, E. Aalbersberg, 2022, EJNMMI Radiopharmacy and Chemistry.

Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.

J. Schellens, H. Rosing, J. Beijnen, 2014, Biomedical chromatography : BMC.

A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry.

J. Schellens, H. Rosing, J. Beijnen, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet

J. Schellens, J. Beijnen, A. Huitema, 2013, Drug Delivery and Translational Research.

Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)

J. Beijnen, L. van Andel, M. Stokkel, 2020, EJNMMI Radiopharmacy and Chemistry.

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine

J. Sonke, A. Al-Mamgani, W. Vogel, 2021, EJNMMI Research.

Fixed Dosing of Monoclonal Antibodies in Oncology

J. Schellens, J. Beijnen, E. Voest, 2017, The oncologist.

Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery

E. Aalbersberg, J. Hendrikx, M. M. Geluk-Jonker, 2022, EJNMMI Radiopharmacy and Chemistry.

Apical ABC transporters and cancer chemotherapeutic drug disposition.

A. Schinkel, S. Durmuş, J. Hendrikx, 2015, Advances in cancer research.

A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors

H. Rosing, J. Beijnen, A. Huitema, 2020, Clinical pharmacology in drug development.

Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab.

S. Sleijfer, J. Aerts, R. V. van Leeuwen, 2022, The Lancet. Oncology.

Follow up survey for implementation of fixed-dosing of monoclonal antibodies

J. Beijnen, K. Heinhuis, J. Hendrikx, 2020, International Journal of Clinical Pharmacy.

Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet

J. Schellens, J. Beijnen, A. Huitema, 2013, Drug Delivery and Translational Research.

A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer

E. Smit, C. H. van der Leest, M. Deenen, 2023, Targeted Oncology.

Crizotinib-induced fatal fulminant liver failure.

J. Schellens, J. Beijnen, A. Huitema, 2016, Lung cancer.

A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients

J. Beijnen, A. Huitema, T. Dorlo, 2023, EJNMMI Research.

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177Lu‐PSMA‐617 in prostate cancer patients

Steffie M. B. Peters, A. Huitema, J. Nagarajah, 2023, CPT: pharmacometrics & systems pharmacology.

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer

E. Rijkhorst, J. Hendrikx, B. J. de Wit-van der Veen, 2022, The Journal of Nuclear Medicine.

Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling

A. Huitema, J. Hendrikx, B. J. de Wit-van der Veen, 2023, EJNMMI Research.

Redispensing of expensive oral anticancer medicines: A practical application.

J. Beijnen, A. Huitema, B. Nuijen, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

The effect of complementary and alternative medicines on CYP3A4‐mediated metabolism of three different substrates: 7‐benzyloxy‐4‐trifluoromethyl‐coumarin, midazolam and docetaxel

J. Schellens, H. Rosing, J. Beijnen, 2014, The Journal of pharmacy and pharmacology.

A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors

J. Beijnen, T. Dorlo, J. Hendrikx, 2021, EJNMMI Research.

Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry.

A. C. Dubbelman, J. Schellens, H. Rosing, 2013, Rapid communications in mass spectrometry : RCM.

The effect of long-acting somatostatin analogues on the uptake of [^177Lu]Lu-HA-DOTATATE

M. Tesselaar, E. Aalbersberg, J. Hendrikx, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough

E. Aalbersberg, J. Hendrikx, M. Stokkel, 2022, EJNMMI Research.

: predicting

J. Beijnen, A. Huitema, T. Dorlo, 2023 .

Current use and future potential of (physiologically based) pharmacokinetic modelling of radiopharmaceuticals: a review

A. Huitema, J. Hendrikx, B. J. de Wit-van der Veen, 2022, Theranostics.

The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68 Ga - 1 PSMA-11 PET/CT in Primary Prostate Cancer Patients

E. Rijkhorst, J. Hendrikx, H. Siebinga, 2022 .

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel

J. Schellens, H. Rosing, J. Beijnen, 2013, International journal of cancer.

The cycle effect quantified: reduced tumour uptake in subsequent cycles of [^177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy

J. Hendrikx, B. J. de Wit-van der Veen, H. Siebinga, 2023, European journal of nuclear medicine and molecular imaging.